This week, Dr. Peter Mugyenyi is visiting Washington from Uganda, where he directs the Joint Clinical Research Center, the largest PEPFAR implementer in East Africa. Dr. Mugyenyi was one of a half-dozen people in the room when PEPFAR was conceived back in 2003. As one of the program’s most eloquent supporters, Dr. Mugyenyi has recently begun voicing grave concern about the near flat-funding of PEPFAR’s budget. In this video interview, he talks about the on-the-ground consequences of a pullback from the fight against global AIDS. Dr. Mugyenyi will be testifying about this issue on Thursday at a hearing before a House Foreign Affairs subcommittee.
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Haiti already faced a daunting path to recovery in the wake of the catastrophic 2010 earthquake that destroyed much of its capital city, with devastating damage […]